ALGN — Align Technology, Inc. stock price, charts and financials

QT50Align Technology, Inc.

Align Technology, Inc. (NASDAQ: ALGN) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
173.27
+0.38+0.22%
ALGNQT50Align Technology, Inc.·NASDAQ
173.27+0.22%
TA
Loading chart...
Signal & projected range
QT Score downgradeHistorical pattern — not a prediction
Range still being built for this setupWe don’t yet have a frozen historical track record for qt score downgrade to describe a reliable spread of outcomes. The projected range appears once its backtest is established.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
IndexS&P 500P/E30.08EPS (ttm)5.76Insider Own1.02%Shs Outstand71.62MPerf Week-1.33%
Market Cap12.41BForward P/E13.84EPS next Y12.52Insider Trans-1.09%Shs Float66.91MPerf Month-8.03%
Enterprise Value11.48BPEG2.79EPS next Q2.81Inst Own-Short Float7.21%Perf Quarter0.81%
Income414.00MP/S3.00EPS this Y95.83%Inst Trans-Short Ratio4.63Perf Half Y5.89%
Sales4.14BP/B2.93EPS next Y11.00%ROA6.44%Short Interest4.83MPerf YTD10.96%
Book/sh59.09P/C11.25EPS next 5Y10.80%ROE10.09%52W High200.45 -13.56%Perf Year26.92%
Cash/sh15.40P/FCF16.03EPS past 3/5Y7.02% -24.09%ROIC8.90%52W Low122.00 42.02%Perf 3Y-54.63%
Dividend Est.-EV/EBITDA14.59Sales past 3/5Y2.61% 10.30%Gross Margin66.48%Volatility4.75% 3.89%Perf 5Y-72.30%
Dividend TTM-EV/Sales2.77EPS Y/Y TTM2.49%Oper. Margin13.33%ATR (14)7.47Perf 10Y105.86%
Dividend Ex-Date-Quick Ratio1.28Sales Y/Y TTM3.53%Profit Margin9.99%RSI (14)48.76Recom2.33
Dividend Gr. 3/5Y-Current Ratio1.40EPS Q/Q6.02%SMA20-1.00%Beta1.62Target Price204.90
Payout0.00%Debt/Eq0.03Sales Q/Q4.35%SMA50-0.50%Rel Volume1.06Prev Close172.89
Employees20,290LT Debt/Eq0.02EarningsOct 28SMA2003.66%Avg Volume1.03MPrice173.27
IPO DateJan 30, 2001Option/ShortYes / YesEPS/Sales Surpr.0.91% 0.40%Net Debt/EBITDA-1.29Volume1,085,645Change0.22%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-23-26ReiteratedUBSNeutral$186$189
Jul-08-26InitiatedBMO CapitalOutperform$209
Apr-24-26ReiteratedMorgan StanleyEqual Weight$154$188
Apr-21-26ReiteratedPiper SandlerOverweight$220$235
Mar-17-26UpgradeBarclaysEqual WeightOverweight
Feb-09-26UpgradeHSBCHoldBuy$200
Feb-05-26ReiteratedStifel NicolausBuy$200$210
Feb-05-26ReiteratedRobert W. Baird$205$218
Feb-05-26ReiteratedPiper SandlerOverweight$200$220
Feb-05-26ReiteratedWells FargoOverweight$200
Latest News
Aug-04-26
Aug-03-26
Jul-31-26
Jul-30-26
Jul-29-26
Company

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue4,1404,0353,9993,8623,7353,9532,4722,4071,966
Cost of Goods Sold Incl. D&A1,3871,2781,2001,1551,1011,017709663519
Gross Profit2,7522,7572,7992,7072,6342,9351,7631,7441,448
Selling, General and Administrative Excl. Other1,7871,7561,7631,7031,6741,7091,2011,072852
Research and Development377370364347305250175157129
Other Operating Expense371565141200-280
Operating Income552616608643643976387542467
Interest Expense
200000000
Unusual Expense
Non-Operating Income (Expense)18-311-2-4436-813-9
Net Income Before Taxes5705856096415991,012379555458
Income Taxes155175188196237240-1,39711258
Consolidated Net Income4144104214453627721,776443400
Net Income From Continuing Operations4144104214453627721,776443400
Net Income4144104214453627721,776443400
EPS (Recurring)5.765.665.635.824.629.7822.555.575.00
EPS (Basic, Before Extraordinaries)5.765.665.635.824.629.7822.555.575.00
EPS (Diluted)5.765.655.625.814.619.6922.415.534.92
EBITDA7877668177997801,121481593521
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio30.0827.6437.1047.1645.7567.8223.8550.4642.57
Price To Sales Ratio2.972.833.915.394.4013.1317.089.168.52
Gross Margin66.4768.3369.9970.0970.5274.2571.3272.4673.65
Operating Margin13.3315.2715.2016.6517.2224.6915.6622.5223.75
Net Margin10.0010.1610.5311.529.6919.5371.8418.4020.35
Shares Outstanding717375767879797980
Market Capitalization12,30211,39915,63820,82416,45051,91742,21622,04416,754
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$219.54$192.79$166.03$139.28$112.53 Close Price0.00M0.38M0.75M1.13M1.51MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Conroy Kevin TDirectorMay 20 '26Option Exercise0.001,74503,553May 22
MORROW GEORGE JDirectorMay 20 '26Option Exercise0.001,74505,036May 22
Vitalone Britt J.DirectorMay 20 '26Option Exercise0.001,44301,443May 22
Saia Andrea LynnDirectorMay 20 '26Option Exercise0.001,745017,318May 22
Poul MojdehDirectorMay 20 '26Option Exercise0.001,74503,553May 22
Myong AnneDirectorMay 20 '26Option Exercise0.001,74509,830May 22
SIEGEL SUSAN EDirectorMay 20 '26Option Exercise0.001,745010,723May 22
LARKIN C RAYMOND JRDirectorMay 20 '26Option Exercise0.002,326027,454May 22
Dallas Kevin JDirectorMay 20 '26Option Exercise0.001,745016,168May 22
LACOB JOSEPHDirectorMay 20 '26Option Exercise0.001,7450135,916May 22
Coletti Julie AnnEVP, CHIEF LEGAL & REGULATORYFeb 20 '26Option Exercise0.0011,728013,163Feb 24
HOGAN JOSEPH MPresident and CEOFeb 20 '26Option Exercise0.0080,4963225,377Feb 24
Morici JohnEVP, CHIEF FINANCIAL OFFICERFeb 20 '26Option Exercise0.0015,696016,085Feb 24
Hockridge Stuart AEVP, GLOBAL HRFeb 20 '26Option Exercise0.008,620016,102Feb 24
Morici JohnEVP, CHIEF FINANCIAL OFFICERFeb 18 '26Sale189.317,9691,508,6468,237Feb 20
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.